GO:0010626 | negative regulation of Schwann cell proliferation | 1.84e-03 | 1.00e+00 | 9.083 | 1 | 1 | 3 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0044212 | transcription regulatory region DNA binding | 3.07e-03 | 1.00e+00 | 4.509 | 2 | 13 | 143 |
GO:0006356 | regulation of transcription from RNA polymerase I promoter | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 5 |
GO:0050847 | progesterone receptor signaling pathway | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 3.68e-03 | 1.00e+00 | 8.083 | 1 | 3 | 6 |
GO:0031643 | positive regulation of myelination | 4.29e-03 | 1.00e+00 | 7.861 | 1 | 1 | 7 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 4 | 8 |
GO:0071354 | cellular response to interleukin-6 | 5.52e-03 | 1.00e+00 | 7.499 | 1 | 1 | 9 |
GO:0005743 | mitochondrial inner membrane | 5.76e-03 | 1.00e+00 | 4.046 | 2 | 9 | 197 |
GO:0005736 | DNA-directed RNA polymerase I complex | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 4 | 10 |
GO:0001054 | RNA polymerase I activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 6.74e-03 | 1.00e+00 | 7.209 | 1 | 4 | 11 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 7.96e-03 | 1.00e+00 | 6.968 | 1 | 3 | 13 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 14 |
GO:0006386 | termination of RNA polymerase III transcription | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 8.57e-03 | 1.00e+00 | 6.861 | 1 | 2 | 14 |
GO:0000188 | inactivation of MAPK activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 15 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.10e-02 | 1.00e+00 | 6.499 | 1 | 3 | 18 |
GO:0071897 | DNA biosynthetic process | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 2 | 20 |
GO:0008180 | COP9 signalosome | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 6 | 24 |
GO:0008137 | NADH dehydrogenase (ubiquinone) activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 2 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 5 | 24 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 2 | 25 |
GO:0005747 | mitochondrial respiratory chain complex I | 1.59e-02 | 1.00e+00 | 5.968 | 1 | 2 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 1.65e-02 | 1.00e+00 | 5.914 | 1 | 4 | 27 |
GO:0006383 | transcription from RNA polymerase III promoter | 1.77e-02 | 1.00e+00 | 5.810 | 1 | 6 | 29 |
GO:0051865 | protein autoubiquitination | 1.89e-02 | 1.00e+00 | 5.714 | 1 | 2 | 31 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.01e-02 | 1.00e+00 | 3.110 | 2 | 21 | 377 |
GO:0007254 | JNK cascade | 2.07e-02 | 1.00e+00 | 5.581 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 5 | 35 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 6 | 40 |
GO:0032481 | positive regulation of type I interferon production | 2.91e-02 | 1.00e+00 | 5.083 | 1 | 3 | 48 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 3.15e-02 | 1.00e+00 | 4.968 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 3.21e-02 | 1.00e+00 | 4.941 | 1 | 6 | 53 |
GO:0022904 | respiratory electron transport chain | 3.27e-02 | 1.00e+00 | 4.914 | 1 | 3 | 54 |
GO:0042826 | histone deacetylase binding | 3.51e-02 | 1.00e+00 | 4.810 | 1 | 5 | 58 |
GO:0030308 | negative regulation of cell growth | 4.23e-02 | 1.00e+00 | 4.539 | 1 | 3 | 70 |
GO:0001649 | osteoblast differentiation | 4.46e-02 | 1.00e+00 | 4.459 | 1 | 5 | 74 |
GO:0044237 | cellular metabolic process | 4.52e-02 | 1.00e+00 | 4.440 | 1 | 3 | 75 |
GO:0005737 | cytoplasm | 4.89e-02 | 1.00e+00 | 1.306 | 4 | 127 | 2633 |
GO:0005515 | protein binding | 5.22e-02 | 1.00e+00 | 0.981 | 5 | 198 | 4124 |
GO:0016323 | basolateral plasma membrane | 6.34e-02 | 1.00e+00 | 3.941 | 1 | 3 | 106 |
GO:0042981 | regulation of apoptotic process | 6.69e-02 | 1.00e+00 | 3.861 | 1 | 4 | 112 |
GO:0008270 | zinc ion binding | 6.79e-02 | 1.00e+00 | 2.163 | 2 | 39 | 727 |
GO:0008022 | protein C-terminus binding | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 5 | 115 |
GO:0007049 | cell cycle | 6.86e-02 | 1.00e+00 | 3.823 | 1 | 8 | 115 |
GO:0000398 | mRNA splicing, via spliceosome | 7.61e-02 | 1.00e+00 | 3.668 | 1 | 15 | 128 |
GO:0005654 | nucleoplasm | 9.46e-02 | 1.00e+00 | 1.894 | 2 | 68 | 876 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 9.50e-02 | 1.00e+00 | 3.338 | 1 | 18 | 161 |
GO:0008380 | RNA splicing | 9.72e-02 | 1.00e+00 | 3.302 | 1 | 21 | 165 |
GO:0005634 | nucleus | 9.92e-02 | 1.00e+00 | 1.004 | 4 | 158 | 3246 |
GO:0004842 | ubiquitin-protein transferase activity | 1.05e-01 | 1.00e+00 | 3.185 | 1 | 17 | 179 |
GO:0006281 | DNA repair | 1.18e-01 | 1.00e+00 | 3.003 | 1 | 24 | 203 |
GO:0019899 | enzyme binding | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 7 | 210 |
GO:0008285 | negative regulation of cell proliferation | 1.59e-01 | 1.00e+00 | 2.555 | 1 | 11 | 277 |
GO:0045892 | negative regulation of transcription, DNA-templated | 1.80e-01 | 1.00e+00 | 2.360 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.92e-01 | 1.00e+00 | 2.255 | 1 | 23 | 341 |
GO:0016032 | viral process | 2.36e-01 | 1.00e+00 | 1.927 | 1 | 30 | 428 |
GO:0045087 | innate immune response | 2.48e-01 | 1.00e+00 | 1.848 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 2.49e-01 | 1.00e+00 | 1.836 | 1 | 29 | 456 |
GO:0070062 | extracellular vesicular exosome | 2.67e-01 | 1.00e+00 | 0.988 | 2 | 51 | 1641 |
GO:0010467 | gene expression | 2.87e-01 | 1.00e+00 | 1.605 | 1 | 49 | 535 |
GO:0005829 | cytosol | 3.03e-01 | 1.00e+00 | 0.865 | 2 | 88 | 1787 |
GO:0005887 | integral component of plasma membrane | 3.05e-01 | 1.00e+00 | 1.501 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 3.25e-01 | 1.00e+00 | 1.397 | 1 | 24 | 618 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.36e-01 | 1.00e+00 | 1.338 | 1 | 29 | 644 |
GO:0005739 | mitochondrion | 3.43e-01 | 1.00e+00 | 1.304 | 1 | 32 | 659 |
GO:0005576 | extracellular region | 3.44e-01 | 1.00e+00 | 1.296 | 1 | 15 | 663 |
GO:0006355 | regulation of transcription, DNA-templated | 3.66e-01 | 1.00e+00 | 1.187 | 1 | 31 | 715 |
GO:0044281 | small molecule metabolic process | 4.19e-01 | 1.00e+00 | 0.947 | 1 | 35 | 844 |
GO:0003677 | DNA binding | 4.58e-01 | 1.00e+00 | 0.781 | 1 | 52 | 947 |
GO:0006351 | transcription, DNA-templated | 5.04e-01 | 1.00e+00 | 0.597 | 1 | 47 | 1076 |
GO:0016020 | membrane | 5.47e-01 | 1.00e+00 | 0.431 | 1 | 56 | 1207 |